文献速递心律失常冠心病

空腹血糖水平与非瓣膜性房颤患者血栓栓塞事件的关系

[The relationship between fasting blood glucose level and thromboembolism events in patients with non-valvular atrial fibrillation].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2022-01-01

基于中国多中心前瞻性房颤注册队列18 703例NVAF患者,按入院空腹血糖及糖尿病状态分5组随访(51±23)个月。Kaplan-Meier及多因素Cox回归显示,糖尿病前期、血糖控制严格(含血糖过低)及血糖控制不佳者血栓栓塞风险均较血糖正常组升高,提示空腹血糖过高或过低可能是NVAF患者血栓栓塞事件的独立危险因素。

要点

  • 糖尿病前期、血糖控制严格及控制不佳的NVAF患者血栓栓塞风险均高于血糖正常者。
  • 严格控制血糖组中29.0%入院空腹血糖<4.4 mmol/L,该组血栓栓塞风险亦升高。
  • 空腹血糖过高或过低均可能是NVAF患者血栓栓塞事件的独立危险因素。

核心结论

  • 空腹血糖升高或者过低可能是NVAF患者发生血栓栓塞事件的独立危险因素。

研究设计与样本

  • 本研究为基于多中心、前瞻性中国房颤注册队列的观察性研究,连续纳入2011年8月至2018年12月北京市31家医院的NVAF患者18 703例。
  • 按入院时是否合并糖尿病及空腹血糖水平分为血糖正常组、糖尿病前期组、血糖控制严格的糖尿病组、血糖控制一般的糖尿病组和血糖控制不佳的糖尿病组,每6个月门诊或电话随访,采用Kaplan-Meier生存分析和多因素Cox回归分析。

主要发现

  • 随访(51±23)个月(最长82个月),984例(5.3%)患者发生血栓栓塞事件。
  • 血糖正常组、糖尿病前期组、血糖控制严格组、血糖控制一般组和血糖控制不佳组的血栓栓塞事件发生率分别为1.10/100、1.41/100、2.09/100、1.46/100和1.71/100人年(χ²=53.0,log-rank P<0.001)。
  • 上述5组复合终点事件发生率分别为1.86/100、2.17/100、4.08/100、2.58/100和3.16/100人年(χ²=72.3,log-rank P<0.001),其余4组均较血糖正常组高(P均<0.001)。
  • 多因素Cox回归显示,与血糖正常组相比,糖尿病前期组(HR=1.23,95%CI 1.00~1.51,P=0.049)、血糖控制严格的糖尿病组(HR=1.32,95%CI 1.06~1.65,P=0.013)和血糖控制不佳的糖尿病组(HR=1.26,95%CI 1.01~1.58,P=0.044)血栓栓塞风险升高。
  • 已明确诊断糖尿病的4 803例患者中,严格控制血糖达标1 131例(23.5%),其中入院空腹血糖<4.4 mmol/L者328例(29.0%)。

临床怎么用

  • 对NVAF患者评估血栓栓塞风险时,除关注高血糖外,也应关注空腹血糖过低(如<4.4 mmol/L)带来的风险信号。
  • 糖尿病前期及血糖控制不佳的NVAF患者血栓栓塞风险升高,提示需综合管理血糖并评估抗凝策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the relationship between fasting blood glucose level and thromboembolism events in patients with non-valvular atrial fibrillation (NVAF). Methods: This was an observational study based on data from a multicenter, prospective Chinese atrial fibrillation registry cohort, which included 18 703 consecutive patients with atrial fibrillation (AF) in 31 hospitals in Beijing from August 2011 to December 2018. Patients were divided into 5 groups according to status of comorbid diabetes and fasting glucose levels at admission: normal blood glucose (normal glucose group), pre-diabetes group, strict glycemic control group, average glycemic control group and poor glycemic control group. Patients were followed up by telephone or outpatient service every 6 months. The primary follow-up endpoint was thromboembolic events, including ischemic stroke and systemic embolism. The secondary endpoint was the composite endpoint of cardiovascular death and thromboembolic events. Kaplan-Meier survival analysis and multifactorial Cox regression were used to analyze the correlation between fasting glucose levels and endpoint events. Results: The age of 18 703 patients with NVAF was (63.8±12.0) years, and there were 11 503 (61.5%) male patients. There were 11 877 patients (63.5%) in normal blood glucose group, 2 023 patients (10.8%)in pre-diabetes group, 1 131 patients (6.0%) in strict glycemic control group, 811 patients in average glycemic control group and 2 861 patients(4.3%) in poor glycemic control group. Of the 4 803 diabetic patients, 1 131 patients (23.5%) achieved strict glycemic control, of whom 328 (29.0%) were hypoglycemic (fasting blood glucose level<4.4 mmol/L at admission). During a mean follow-up of (51±23) months (up to 82 months), thromboembolic events were reported in 984 patients (5.3%). The survival curve analysis of Kaplan Meier showed that the incidence rates of thromboembolic events in normal glucose group, pre-diabetes group, strict glycemic control group, average glycemic control group and poor glycemic control group were 1.10/100, 1.41/100, 2.09/100, 1.46/100 and 1.71/100 person-years, respectively (χ²=53.0, log-rank P<0.001). The incidence rates of composite endpoint events were 1.86/100, 2.17/100, 4.08/100, 2.58/100, 3.16/100 person-years (χ²=72.3, log-rank P<0.001). The incidence of thromboembolic events and composite endpoint events in the other four groups were higher than that in the normal blood glucose group (P<0.001). Multivariate Cox regression analysis showed that compared with normal glucose group, the risk of thromboembolism increased in pre-diabetes group(HR=1.23, 95%CI 1.00-1.51, P=0.049), strict glycemic control group(HR=1.32, 95%CI 1.06-1.65, P=0.013) and poor glycemic control group(HR=1.26, 95%CI 1.01-1.58, P=0.044). Conclusion: Both high or low fasting glucose may be an independent risk factor for thromboembolic events in patients with NVAF. 目的: 探讨空腹血糖水平与非瓣膜性心房颤动(NVAF)患者血栓栓塞事件发生的关系。 方法: 本研究为前瞻性队列研究,研究数据来自多中心、前瞻性中国房颤注册队列研究,根据纳入及排除标准,连续纳入2011年8月至2018年12月北京市31家医院的NVAF患者18 703例,根据患者入院时是否合并糖尿病及其空腹血糖水平,将患者分为5组,分别为血糖正常组、糖尿病前期组、血糖控制严格的糖尿病组、血糖控制一般的糖尿病组和血糖控制不佳的糖尿病组。患者入组后每6个月进行门诊或电话随访,主要随访终点为血栓栓塞事件,包括缺血性卒中和系统性栓塞;次要终点为心血管死亡和血栓栓塞事件的复合终点。采用Kaplan-Meier生存分析和多因素Cox回归分析空腹血糖水平与终点事件之间的相关性。 结果: 纳入的18 703例NVAF患者年龄(63.8±12.0)岁,男性11 503例(61.5%)。其中血糖正常组11 877例(63.5%)、糖尿病前期组2 023例(10.8%)、血糖控制严格的糖尿病组1 131例(6.0%)、血糖控制一般的糖尿病组811例(4.3%),血糖控制不佳的糖尿病组2 861例(15.3%)。已经明确诊断为糖尿病的4 803例患者中,严格控制血糖达标的患者共1 131例(23.5%),其中血糖过低(入院时空腹血糖水平<4.4 mmol/L)的患者有328例(29.0%)。随访(51±23)个月,最长82个月,随访结束时984例(5.3%)患者发生血栓栓塞事件。Kaplan-Meier生存曲线分析显示,血糖正常组、糖尿病前期组、血糖控制严格的糖尿病组、血糖控制一般的糖尿病组和血糖控制不佳的糖尿病组的NVAF患者血栓栓塞事件发生率分别为1.10/100、1.41/100、2.09/100、1.46/100和1.71/100人年(χ²=53.0,log-rank P<0.001);复合终点事件发生率分别为:1.86/100、2.17/100、4.08/100、2.58/100、3.16/100人年(χ²=72.3,log-rank P<0.001);血栓栓塞事件和复合终点事件发生率其余4组均较血糖正常组高(P均<0.001)。多因素Cox回归分析显示,与血糖正常组相比,糖尿病前期组(HR=1.23,95%CI 1.00~1.51,P=0.049)、血糖控制严格的糖尿病组(HR=1.32,95%CI 1.06~1.65,P=0.013)和血糖控制不佳的糖尿病组(HR=1.26,95%CI 1.01~1.58,P=0.044)的NVAF患者血栓栓塞风险升高。 结论: 空腹血糖升高或者过低可能是NVAF患者发生血栓栓塞事件的独立危险因素。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Bo, Zuo, Jiang, et al. [The relationship between fasting blood glucose level and thromboembolism events in patients with non-valvular atrial fibrillation]. Zhonghua Xin Xue Guan Bing Za Zhi. 2022. PMID: 35340142. doi:10.3760/cma.j.cn112148-20210419-00351

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。